ArticleJournal of thoracic disease2026
Quantitative CT analysis in lung cancer research: a bibliometric analysis based on Web of Science [2005-2025].
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Quantitative computed tomography (CT) analysis plays an increasingly critical role in the diagnosis, treatment response assessment, and prognostic stratification of lung cancer. However, existing narrative and systematic reviews have not systematically delineated the evolutionary trajectories, knowledge gaps, or quantitative trends in this rapidly growing field. A bibliometric analysis is therefore timely to provide an objective, visual, and reproducible synthesis of research developments, collaboration networks, and emerging frontiers. This study aims to summarize and identify key research areas and developmental trends in quantitative CT analysis for lung cancer, thereby providing a reference for future research. Methods: Articles on quantitative CT analysis of lung cancer published between 1 January 2005 and 3 October 2025 were retrieved from the Web of Science Core Collection (WoSCC). The search strategy employed was: (TS = ("Lung Neoplasms" OR "neoplasm* pulmonary" OR "pulmonary neoplasm*" OR "neoplasm* lung" OR "lung neoplasm" OR "lung cancer*" OR "cancer* lung" OR "cancer of lung" OR "pulmonary cancer*" OR "cancer* pulmonary" OR "cancer of the lung")) AND TS = ("Quantitative CT" OR "Quantitative Computed Tomography" OR "QCT" OR "CT densitometry" OR "Quantitative analysis" OR "Quantitative measurement" OR "Quantitative assessment" OR "Quantitative imaging" OR "3D Quantitative CT"). Inclusion criteria were publications relevant to the topic and published in open access. Exclusion criteria included conference proceedings, meeting abstracts, book chapters, early access publications, editorial material, letters, retracted publications, corrections, retractions, and non‑English publications. Two independent reviewers performed data screening and extraction. Visualization and bibliometric analyses (publication output, author collaboration networks, journal citations, and keywords) were conducted using CiteSpace and bioinformatics platforms. Results: A total of 1,618 publications were included. The United States and China were the most productive countries. Robert J. Gillies served as a key bridge connecting different research groups. The Conclusions: Quantitative CT analysis in lung cancer has evolved into a mature, multidisciplinary field. Despite rapid growth, major limitations remain: most studies are single‑centre and retrospective; CT acquisition and radiomic feature extraction protocols are not standardized; and external validation of artificial intelligence (AI) models is scarce. To address these gaps, future research should prioritize prospective multicentre trials, harmonization of scanning and analysis protocols, integration of quantitative CT with multi‑omics data, development of explainable and generalizable AI models, and standardized reporting of model performance. These steps will accelerate clinical translation toward precision diagnostics and therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.